EMPI INC
10-Q/A, 1995-09-21
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: FMR CORP, SC 13D/A, 1995-09-21
Next: GENENTECH INC, DEFM14A, 1995-09-21



<PAGE>
                                     FORM 10-QA

                         SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, D. C.  20549


                    Quarterly Report Under Section 13 or 15 (d)
                      of the Securities Exchange Act of 1934

          For Quarter Ended        June 30, 1995
                             -------------------------------------

              Commission File Number    0-9387
                                    ------------------------------
                                       Empi, Inc.
                                    -----------------

                 (Exact name of registrant as specified in its charter)


                    Minnesota                        41-1310335
             ----------------------             ----------------------

       (State or other jurisdiction of             (I.R.S. employer
        incorporation or organization)            identification no.)

           5255 East River Road
          Minneapolis, Minnesota                          55421
       ----------------------------              ----------------------
          (Address of principal                        (Zip code)
            executive offices)


Registrant's telephone number, including area code  (612) 586-7300
                                                    --------------


Indicate by check mark whether the registrant  (1)  has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

Yes  /x/   No  / /


8,594,554 shares of Common Stock were outstanding as of August 10, 1995.


                       This document contains 12 pages.
                        The Exhibit Index is on page 4.

                                      1
<PAGE>

                                     SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereto duly authorized.

                     Empi, Inc.


August 29, 1995    By        /s/ Joseph E. Laptewicz
                    ---------------------------------------
                                 Joseph E. Laptewicz
                       President and Chief Executive Officer
                            (Principal Executive Officer)


August 29, 1995   By            /s/ Timothy E. Briggs
                    ---------------------------------------
                                    Timothy E. Briggs
                              Executive Vice President and
                                Chief Financial Officer
                    (Principal Financial and Accounting Officer)

                                        5

<PAGE>


FORM 10 - QA - - PART I - ITEM 1

EMPI, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)

<TABLE>
<CAPTION>
                                                                          Six Months Ended,
                                                                               June 30
                                                             1995                                  1994
                                                             ----                                  ----
                                                          (unaudited)                           (unaudited)
<S>                                                       <C>                                   <C>
OPERATING ACTIVITIES
  Net income                                                $ 3,647                               $ 2,992
  Adjustments to reconcile net income to net
    cash provided by (used in) operating activities:
     Depreciation and amortization                            1,635                                 1,539
     Provision for deferred income taxes                       (408)                                 (462)
     Gain on sale of long-term investments                      (70)                                  ---
     Loss on sale of equipment                                    5                                     4
     Provision for loss on accounts receivable                1,269                                 1,524
     Changes in operating assets and liabilities:
       Decrease in accounts receivable                           83                                   404
       Increase in inventories                               (1,159)                               (1,298)
       Increase in other assets/liabilities                    (253)                                 (288)
       Increase (decrease) in accounts payable
         and accrued expenses                                    57                                  (542)
       Increase (decrease) in income taxes payable             (465)                                  203
                                                            -------                               -------

NET CASH PROVIDED BY (USED IN)
OPERATING ACTIVITIES                                          4,341                                 4,076

INVESTING ACTIVITIES
  Sale of short-term investments                              1,796                                   500
  Additions to other assets                                     ---                                  (222)
  Purchase of equipment and improvements                       (675)                                 (987)
  Proceeds from sale of equipment                                 9                                   ---
  Purchase of short-term investments                         (1,870)                               (3,041)
  Sale of long-term investments                                 150                                   ---
  Purchase of long-term investments                          (2,479)                                  ---
                                                            -------                               -------

NET CASH PROVIDED BY (USED IN)
INVESTING ACTIVITIES                                         (3,069)                               (4,865)

FINANCING ACTIVITIES
  Payments on long-term debt                                     (3)                                   (6)
  Proceeds from exercise of Common Stock options                 36                                    88
                                                            -------                               -------
NET CASH PROVIDED BY FINANCING ACTIVITIES                        33                                    82
                                                            -------                               -------

NET INCREASE IN CASH AND
CASH EQUIVALENTS                                              1,305                                  (707)

  Cash and cash equivalents at beginning of year              5,652                                 6,231
                                                            -------                               -------

CASH AND CASH EQUIVALENTS AT
END OF PERIOD                                               $ 6,957                               $ 5,524
                                                            -------                               -------
                                                            -------                               -------
</TABLE>


See notes to condensed consolidated financial statements.

                                      10



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission